Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent. Kress HG(1), Boss H, Delvin T, Lahu G, Lophaven S. The pharmacokinetic profiles of the two commercially available transdermal fentanyl patches Matrifen® ( μg/h) and Durogesic® DTrans® ( μg/h), used to. Some recent orders of Durogesic DTrans (fentanyl; Janssen-Cilag) 25µg/hour transdermal patches, batch number 8FCSC00, may have been incorrectly filled.

Author: Voll Tygor
Country: India
Language: English (Spanish)
Genre: Love
Published (Last): 26 July 2015
Pages: 200
PDF File Size: 12.2 Mb
ePub File Size: 10.46 Mb
ISBN: 111-4-86158-905-8
Downloads: 17148
Price: Free* [*Free Regsitration Required]
Uploader: Yokus

Each Durogesic DTrans 12 patch contains fentanyl 2. The serum fentanyl concentrations attained are proportional to the Durogesic DTrans patch size. Chronic pulmonary disease Durogesic DTrans may have more severe adverse effects in patients with chronic obstructive or other pulmonary disease. Elimination Following a hour patch application, the mean fentanyl half-life ranges from 20 to 27 hours. For commenting, please login or register as a user and agree to our Community Guidelines.

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Latest Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease 5 NOV It also crosses the placenta and is excreted in breast milk. The dose should be titrated individually on the basis of average daily use of supplemental analgesics, until a balance between analgesic efficacy and tolerability is attained.

Patients reach and maintain a steady-state serum concentration that is determined by individual variation in skin permeability and body clearance of fentanyl.

The safety profile in children and adolescents treated with Durogesic DTrans was similar to that observed in dtgans. Putting a patch on Step 1: The conversion schedule should not be used to convert from Durogesic DTrans into other opioids, as overdosing could then occur. Moreover, because fentanyl passes through the placenta, the use of Durogesic DTrans during childbirth might result in respiratory depression in the newborn infant.


Patients can then switch to Durogesic DTrans. Fentanyl citrate is used parenterally to provide preoperative anxiolysis and sedation and as a supplement to anesthesia. Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. Accidental transfer of a fentanyl patch to the skin of a non-patch wearer particularly a childdutogesic sharing a bed or being in close physical contact with a patch wearer, may result in an opioid overdose for the non-patch wearer.

A new patch should be applied to a different skin site after removal of the previous transdermal patch.

Convert this amount to the equianalgesic hour oral morphine dose using the multiplication factors in Table 1 for the appropriate route of administration. Table 2 is for adult patients who tdrans a need for opioid rotation or who are less clinically stable conversion ratio of oral morphine to transdermal fentanyl approximately equal to Do not drink alcohol while using Durogesic DTrans unless you have talked to your doctor first.

Durogesic DTrans 12 mcg/hr Transdermal Patch

It should be noted that this conversion schedule for children only applies to the switch from oral morphine or its equivalent to Durogesic DTrans patches. To derive the Durogesic DTrans dosage corresponding to the calculated hour, equianalgesic morphine dosage, use dosage-conversion Table 2 or 3 as follows:.

Patients with myasthenia gravis Non-epileptic myo clonic reactions can occur. Accidental exposure by patch transfer Accidental transfer of a fentanyl patch to the skin of a non-patch wearer particularly a childwhile sharing a bed or being in close physical contact with dtrahs patch wearer, may result in an opioid overdose for the non-patch wearer.


Studies in animals have shown some reproductive toxicity see section 5. Recommended from Pharmaceutical Press Previous Next.

Latest Drug Information Updates. Ultomiris Ultomiris ravulizumab-cwvz is a long-acting C5 complement inhibitor for the treatment dfrans paroxysmal All patients should be advised to avoid exposing the Durogesic DTrans application site to direct external heat sources such as heating pads, electric blankets, heated water beds, heat or tanning lamps, sunbathing, hot water bottles, prolonged hot baths, saunas and hot whirlpool spa baths.

Durogesic DTrans | MIMS online

Latest Celebrating a year of career highlights 12 DEC The expiry date refers to the last date of that month. High inter-subject variability in plasma concentrations has been observed.

Use a new area of skin on: Durogesic DTrans should be administered only to dtfans children age 2 years or older see section 4. Previous analgesic therapy should therefore be gradually phased out after the initial dose application until analgesic efficacy with Durogesic DTrans is attained.

If you are not sure, talk dutogesic your doctor or pharmacist before using Durogesic DTrans. Sign Up Log In Cancel.

Use of Durogesic DTrans during childbirth is not recommended because it should not be used in the management of acute or postoperative pain see section 4. Acute or postoperative pain because there is no opportunity for dose titration during short-term use and because serious or life-threatening hypoventilation could result.

If the analgesic effect of Durogesic DTrans is insufficient, supplementary morphine or another short-duration opioid should be administered. Back to top Janssen-Cilag Ltd contact details.